Metraipolis › archive › dc_51aecc758ef7

Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer — Europe PMC PMID:40946111

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40946111
DOI
10.1038/s41416-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-09T23:32:46.640Z
SHA-256 of the archived text
0f4b7c4c1357733fb3aed5e996e8df51c452930e9fa603b10e7d8df293e9b0d0
Stable URL of this page
https://metraipolis.com/documento/dc_51aecc758ef7

How to cite

Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer — Europe PMC PMID:40946111 — Europe PMC (en), https://europepmc.org/article/MED/40946111 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_51aecc758ef7 (Metraipolis archive dc_51aecc758ef7, sha256 0f4b7c4c1357733fb3aed5e996e8df51c452930e9fa603b10e7d8df293e9b0d0)
BibTeX
@misc{dc51aecc758ef7,
  title = {Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer — Europe PMC PMID:40946111},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40946111},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_51aecc758ef7; sha256 0f4b7c4c1357733fb3aed5e996e8df51c452930e9fa603b10e7d8df293e9b0d0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40946111. Agents can read the archived copy with the MCP tool read_document.